<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">There are thousands of global SARS-CoV-2 whole-genome sequences available on the rapid data sharing service hosted by the Global Initiative on Sharing All Influenza Data (GISAID; 
 <ext-link ext-link-type="uri" xlink:href="https://www.epicov.org" id="ir0025" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.epicov.org</ext-link>) (
 <xref rid="bb0045" ref-type="bibr">Elbe and Buckland-Merrett, 2017</xref>; 
 <xref rid="bb0165" ref-type="bibr">Shu and McCauley, 2017</xref>). The extraordinary availability of genomic data during the COVID-19 pandemic has been made possible thanks to a tremendous effort by hundreds of researchers globally depositing SARS-CoV-2 assemblies (Table S1) and the proliferation of close to real time data visualisation and analysis tools including NextStrain (
 <ext-link ext-link-type="uri" xlink:href="https://nextstrain.org" id="ir0030" xmlns:xlink="http://www.w3.org/1999/xlink">https://nextstrain.org</ext-link>) and CoV-GLUE (
 <ext-link ext-link-type="uri" xlink:href="http://cov-glue.cvr.gla.ac.uk" id="ir0035" xmlns:xlink="http://www.w3.org/1999/xlink">http://cov-glue.cvr.gla.ac.uk</ext-link>).
</p>
